Pharmaceutical - Diabetes, Nephrology and Hepatology

Filter

Popular Filters

Evolva to license EV-077 to Serodus

07-10-2013

Switzerland-based Evolva Holding and Norwegian biopharma company Serodus have signed a binding term…

BiotechnologyDiabetesEV-077EvolvaLicensingNephrology and HepatologyPharmaceuticalSerodus

Scottish Medicines Consortium approves MabThera for vasculitis, Lyxumia for diabetes and Targaxan for liver disease

10-09-2013

Drug regulator the Scottish Medicines Consortium (SMC) has today approved the National Health Service…

DiabetesEuropeHealthcareLyxumiaMabTheraNephrology and HepatologyNorginePharmaceuticalRocheSanofiTargaxan

Back to top